Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,125 CAD | -3,85% | -7,41% | +56,25% |
18/04 | Transcript : Kane Biotech Inc. - Special Call | |
15/04 | Dechra Veterinary Products, Inc. heeft de overname van 66,66% belang in STEM Animal Health Inc. van Kane Biotech Inc. (TSXV:KNE) afgerond. | CI |
Omzet 2022 | 2,67 mln. 1,95 mln. 1,83 mln. | Omzet 2023 | 149K 109K 102K | Marktkapitalisatie | 10,55 mln. 7,71 mln. 7,22 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -3 mln. -2,19 mln. -2,05 mln. | Nettowinst (verlies) 2023 | -5 mln. -3,66 mln. -3,42 mln. | EV/omzet 2022 | 6,37 x |
Nettoschuld 2022 | 5,76 mln. 4,21 mln. 3,94 mln. | Nettoschuld 2023 | 8,51 mln. 6,22 mln. 5,82 mln. | EV/omzet 2023 | 128 x |
K/w-verhouding 2022 |
-2,79
x | K/w-verhouding 2023 |
-2,02
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 65,07% |
Recentste transcriptie over Kane Biotech Inc.
1 dag | -3,85% | ||
1 week | -7,41% | ||
Lopende maand | +25,00% | ||
1 maand | +19,05% | ||
3 maanden | +56,25% | ||
6 maanden | +66,67% | ||
Lopend jaar | +56,25% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Marc Edwards
CEO | Chief Executive Officer | - | 02-06-16 |
Ray Dupuis
DFI | Director of Finance/CFO | - | 05-09-17 |
Compliance Officer | - | 12-08-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
R. Renaud
BRD | Director/Board Member | - | 15-09-10 |
Chairman | 59 | 20/02 | |
Georges Morin
BRD | Director/Board Member | - | 20-05-20 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 0,125 | -3,85% | 31 500 |
25-04-24 | 0,13 | +4,00% | 12 000 |
24-04-24 | 0,125 | -3,85% | 150 900 |
23-04-24 | 0,13 | -7,14% | 27 500 |
22-04-24 | 0,14 | +3,70% | 5 000 |
uitgestelde koers Toronto S.E., 26 april 2024 om 21:44 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+56,25% | 12,04 mln. | |
+1,51% | 42,75 mld. | |
+8,57% | 41,34 mld. | |
+49,22% | 41,61 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |